The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is expected to trade slightly higher today following mixed leads from international markets.

Here’s a recap:

  • FTSE 100 (UK): down 0.62%
  • DAX (Germany): down 0.57%
  • CAC 40 (France): down 0.67%
  • Dow Jones (USA): up 0.01%
  • NASDAQ (USA): up 0.08%

In London, fears of a Brexit continued to weigh on market sentiment, together with poor Chinese factory data. FTSE-listed shares of BHP Billiton Limited (ASX: BHP) and Rio Tinto Limited (ASX: RIO) ended 1.9% and 3.7% lower, respectively.

Over the pond, US markets bucked Europe’s negative lead to trade mostly sideways. The consumer staples and energy sectors were the best-performing while technology and telecommunications shares ended lower.   

Closer to home, the Sydney Futures Exchange is tipping a modest 3-point rise in the S&P/ASX 200.

Shares in focus will include APN News and Media Limited (ASX: APN). Following its planned divestment and the potential merging of its NZME business with Fairfax Media Limited’s (ASX: FXJ) New Zealand businesses, APN announced this morning it had successfully completed its retail shortfall bookbuild. That means institutional investors took up the remaining shares left over from the offer to retail investors.

Sino Gas & Energy Holdings Limited (ASX: SEH) announced additional gas sales agreements with Huashang, a large gas distribution company in the Chinese province of Shanxi.

Patties Foods Limited (ASX: PFL) announced it had entered its Scheme Implementation Deed with a subsidiary of private equity firm Pacific Equity Partners, which plans to acquire the iconic food company.

Mesoblast limited (ASX: MSB) shares will also remain in focus today following the biotechnology company’s decision to enter a trading halt yesterday.

Finally, in broker news:

  • Bell Potter analysts raised their Senetas Corporation Limited (ASX: SEN) price target 7.1% to $0.15;
  • Citi analysts cut their FlexiGroup Limited (ASX: FXL) price target from $3.26 to $2.78; and
  • UBS analysts lifted their Sonic Healthcare Limited (ASX: SHL) from $20.60 to $23.45, according to Dow Jones Newswires.

This stock is a 'Buy'

Sonic Healthcare is good, but I'm looking for other - faster growing - dividend shares to add to my portfolio, like the one The Motley Fool's expert analysts hand-picked as their best dividend share idea for 2016.

Indeed, our resident dividend experts named their Top Dividend Share for 2016. Not only are the shares dirt cheap, the company is growing and trading on a 5.6% fully franked dividend yield. Simply click here to gain access to this comprehensive FREE investment report, including the name of this fast growing ASX dividend share. No credit card required!

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool Contributor Owen Raszkiewicz owns Senetas shares. Owen welcomes -- and encourages -- your feedback on Google+, LinkedIn or you can follow him on Twitter @ASXinvest.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.